EUROIMMUN Logo
Find
X

What are you looking for?

Filter for products in our complete portfolio

Product finder

Worldwide
X
EUROIMMUN worldwide

This website provides an overview of the business activities and products of EUROIMMUN AG worldwide. Not all products are registered and approved in all countries or regions. Please contact your country representative for product availability and information

EUROIMMUN branches

Choose your country

Europe

North America

South & Central America

Asia

Middle East & Africa

EUROIMMUN Logo

Professional articles

by EUROIMMUN

Together at the pulse of neurobiology

Featured in Clinical Laboratory International

A unique portfolio of neurobiomarker tests – The testing landscape for neurological diseases has expanded rapidly in recent years due to the ...

APOE genotype A risk factor for adverse effects from anti-amyloid therapy in Alzheimer’s disease

Featured in Clinical Laboratory International

The apolipoprotein E (APOE) genotype influences the development of Alzheimer’s disease and has recently been found to be a risk factor for side effects ...

Innovations for infectious disease diagnostics

Featured in Practical Patient Care

EUROIMMUN offers an extensive range of test systems for infection diagnostics, including serological assays for antibody determination and PCR-based tests for ...

Serological tests for Crimean- Congo haemorrhagic fever virus aid outbreak management

Featured in Omnia Health

Crimean-Congo haemorrhagic fever (CCHF) is a lifethreatening tick-borne disease that is prioritised by the World Health Organization (WHO) for research and product ...

The growing spectrum of neural autoantibodies and associated syndromes

Autoimmune neurology is a rapidly growing field driven by the ongoing discovery of novel neural autoantibodies associated with recognizable clinical syndromes. These diseases can affect the central, ...

Enhanced myositis diagnostics with new biomarkers

Newer diagnostic strategies now include autoantibodies as biomarkers to aid phenotype classification, malignancy risk assessment, and therapy prognosis.

Biomarkers and preanalytics in Alzheimer’s disease

Featured in Clinical Laboratory International

Analysis of biomarkers such as amyloid-beta peptides and tau proteins in cerebrospinal fluid (CSF) is nowadays a core criterion in Alzheimer's disease ...

Antibody indices – a growing analysis in the diagnosis of CNS diseases

Featured in Omnia Health Magazine

Identification of the causative agent of infectious CNS diseases is essential for providing appropriate treatment.

Page 1 of 10.

Back to top